Independent Franchise Partners recent buys & sells (2024 Q1)
US Equity Fund
US Equity Fund Portfolio Changes
Purchase & sale details
- Portfolio value:
- $1.95B (+$98M)
- Previous value:
- $1.85B
- # of changes:
- 29
- New positions:
- 1
- Reported for:
- 28 Mar 2024 (Q1)
- Latest filing date:
- 28 May 2024
US Equity Fund has disclosed a total of 29 changes to the portfolio in the (2024 Q1) SEC report(s): increased the number of shares of 8, bought 1 totally new, decreased the number of shares of 18 and completely sold out 2 position(s).
What stocks did Independent Franchise Partners buy in 2024 Q1?
During 2024 Q1 Independent Franchise Partners has bought 9 securities out of which top 5 purchases (by % change to portfolio) were (AON) Aon PLC (added shares +38.97%), (PM) Philip Morris International Inc (added shares +20.18%), (BMY) Bristol-Myers Squibb Company (added shares +7.60%), (CTVA) Corteva Inc (added shares +16.59%) and (JNJ) Johnson & Johnson (added shares +105.43%).
What did Independent Franchise Partners invest in during 2024 Q1?
In the 2024 Q1 report(s) the following changes have been made to the top investments: (RBA) RB Global Inc (reduced shares -2.76%), (AON) Aon PLC (added shares +38.97%), (PM) Philip Morris International Inc (added shares +20.18%), (BMY) Bristol-Myers Squibb Company (added shares +7.60%) and (CTVA) Corteva Inc (added shares +16.59%).
29 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Reckitt Benckiser Group PLC
|
new
|
+1,044,049
|
1,044,049
|
+3.05%
|
$56.95
|
+23.18%($70.15)
|
3.05%
|
2024 Q1
|
~0.25 years
|
|
|
|
Johnson & Johnson
|
+105.43%
|
+284,721
|
554,776
|
+2.31%
|
$158.19
|
+66.50%($263.38)
|
4.50%
|
2019 Q3
|
~4.75 years
|
|
|
|
Aon PLC
|
+38.97%
|
+91,146
|
325,063
|
+1.56%
|
$333.72
|
-9.28%($302.76)
|
5.57%
|
2020 Q3
|
~3.75 years
|
|
|
|
Aspen Technology Inc
|
+37.16%
|
+75,854
|
280,005
|
+0.83%
|
$213.28
|
|
3.06%
|
2023 Q2
|
~1.00 year
|
|
|
|
Philip Morris International Inc
|
+20.18%
|
+194,488
|
1,158,264
|
+0.91%
|
$91.62
|
+117.97%($199.70)
|
5.44%
|
2019 Q3
|
~4.75 years
|
|
|
|
Fox Corp, CL-B
|
+18.65%
|
+73,042
|
464,640
|
+0.11%
|
$28.62
|
+109.01%($59.82)
|
0.68%
|
2023 Q2
|
~1.00 year
|
|
|
|
Corteva Inc
|
+16.59%
|
+245,648
|
1,726,494
|
+0.73%
|
$57.67
|
-78.28%($12.52)
|
5.11%
|
2019 Q4
|
~4.50 years
|
|
|
|
Bristol-Myers Squibb Company
|
+7.60%
|
+132,049
|
1,868,497
|
+0.37%
|
$54.23
|
+13.53%($61.57)
|
5.20%
|
2019 Q3
|
~4.75 years
|
|
|
|
Fox Corp, CL-A
|
+1.55%
|
+32,792
|
2,149,029
|
+0.05%
|
$31.27
|
+115.19%($67.29)
|
3.45%
|
2019 Q3
|
~4.75 years
|
|
|
|
Zillow Group Inc
|
-0.31%
|
-6,365
|
2,032,468
|
-0.02%
|
$48.67
|
-29.30%($34.41)
|
5.08%
|
2021 Q4
|
~2.50 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".